Industry-backed trials are positive

An analysis of studies registered on ClinicalTrials.gov showed those funded by industry were more apt to show positive outcomes but less apt to be published shortly after completion than trials funded by other sources.

Out of 546 trials, noted researchers writing in Annals of Internal Medicine, industry-funded trials reported positive outcomes in 85% of publications vs. 50% for government-funded trials, and 72% for nonprofits or non-federal organization-funded trials. The rate of publication within two years of study completion ranged from 32% among industry-funded trials to 56% among nonprofit or nonfederal organization–funded trials without industry contributions.
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters


As US pharma continued its quest for a Grand Prix at the Lions Health international festival of creativity, MM&M went on location to Cannes, France. Missed our coverage from June? Now, we're giving you an opportunity to catch up on some of what you missed. Download our e-book on the two-day festival, recapping the event, rounding up the best of the speakers, offering perspective and listing all of the winners. Click here to download.


The most recent MM&M Skill Sets Live event surveyed a range of issues relating to one of the hottest promotional spaces in healthcare. Speakers and panelists at the morning-long session, including promotional- and multichannel-minded executives from GSK, Epocrates, Treato and Montefiore Medical Center, weighed in on topics designed to help marketers demystify the challenges associated with non-personal promotion. Click here.